Streetbeat News

Assets

SPY

US December exports increased to $258.20 billion from $254.30 billion in the previous month, while imports rose to $320.40 billion from $316.20 billion.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:40 pm

SP

SP Plus (NYSE:SP) has seen a decrease in short interest, with 1.25 million shares sold short, representing 6.4% of its float. This is a decline of 3.47% from its last report, requiring 8.44 days on average for traders to cover their short positions. Short interest is a key indicator of market sentiment, and a decrease suggests a more bullish outlook among investors. SP Plus has a higher short interest compared to its peer group average of 2.75%, indicating more bearish sentiment towards it than its peers.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:30 pm

NOK

Nokia's (NYSE:NOK) short interest has decreased by 17.39%, with 21.09 million shares sold short, representing 0.38% of its float. The current short interest suggests a bullish sentiment compared to its peers, where the average short interest as a percentage of float is 7.75%. This change in short interest could influence Nokia's stock performance in the short term.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:30 pm

PXD

Pioneer Natural Resources (NYSE:PXD) has seen a 3.7% increase in short percent of float since its last report, with 5.20 million shares sold short, representing 2.24% of available shares. This indicates a bearish sentiment among investors, although it's not a definitive predictor of stock price movement. Compared to its peers, PXD has a lower short interest percentage, suggesting it's performing relatively well within its sector.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:30 pm

CLSD

Clearside Biomedical, Inc. (NASDAQ:CLSD) announced a $15M registered direct offering of 11,111,111 shares of common stock and accompanying warrants, priced at $1.35 per share. The warrants, exercisable at $1.62, will be available six months post-issuance and valid for five years. The offering, facilitated by Citizens JMP Securities, LLC as the sole placement agent, is expected to close by February 9, 2024. Clearside aims to use the proceeds for working capital and general corporate purposes, projecting funding sufficiency into Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:23 pm

BAC

Bank of America's Q4 2023 Participant Pulse report reveals a 15% increase in average 401(k) account balances and an 11% increase in Health Savings Account balances. The report, analyzing over 4 million participants, shows a doubling in the percentage of participants who increased their 401(k) contributions in Q4. Additionally, fewer participants took loans from their 401(k) plans, and the average loan amount decreased. The report also highlights that Millennials are saving a higher percentage of their HSA contributions compared to other generations.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:17 pm

XTKG

X3 Holdings Co., Ltd. (NASDAQ:XTKG) has expanded its bitcoin mining operations by deploying 2,000 machines in Central Asia, leveraging hydro-powered and renewable energy sources for sustainability. This move is expected to significantly increase the company's mining capabilities with a hash rate of 0.28EH/s and marks a strategic step towards using eco-friendly energy solutions in its operations.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:15 pm

SKY

Skyline Champion (NYSE:SKY) has seen a decrease in short interest, with 1.40 million shares sold short, representing 3.53% of its float. This is a decline of 11.97% from its last report, indicating a potential shift in market sentiment towards a more bullish outlook compared to its peers, where the average short interest as a percentage of float is 5.22%.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:15 pm

EQIX

Equinix's (NYSE:EQIX) short interest has decreased by 11.39% since the last report, with 1.29 million shares sold short, representing 1.79% of its float. This decline in short interest, which now takes an average of 4.32 days to cover, could indicate a more bullish sentiment towards EQIX compared to its peers, where the average short interest as a percentage of float is 4.01%.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:15 pm

VCNX

Vaccinex, Inc. (VCNX) announced a $3.7 million private placement for the sale of 3,838,544 shares of common stock and warrants. The proceeds, along with funds from a previous offering, are expected to fully fund the SIGNAL-AD trial for Alzheimer's treatment through Q3 2024. The company's lead drug, pepinemab, targets neurodegeneration by inhibiting SEMA4D, showing promise in Alzheimer's and Huntington's disease treatments.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:08 pm